Our panel members shared their thoughts about the impact of the pandemic. Over 1500 healthcare professionals and patients took part of our study.
*Scroll through the infographics to see all results

Psychiatrists warn AI chatbots fail in 20% of mental health crises as millions use them for support amid care shortages. No FDA regulation exists.

Oral JAK inhibitor shows significant skin repigmentation in Phase 3 vitiligo trials, potentially becoming first oral treatment for condition.

Study finds over 70% of hypophosphatasia patients have chronic pain, yet only 1 in 34 receives approved treatment for this rare genetic bone disorder.